MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dry eye in Parkinson’s disease: symptoms, consequences and treatment options

I. Csoti, N. Koleva-Alazeh (Leun, Germany)

Meeting: 2019 International Congress

Abstract Number: 841

Keywords: Autonomic dysfunction, Parkinsonism, Progressive supranuclear palsy(PSP)

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: Dry eye is a common side effect of PD/PSP and easily manageable, yet its occurrence and debilitating ramifications are often unrecognized. The aim of this paper is to explore and thus provide a comprehensive overview of symptoms, consequences and very general treatment options for colleagues and patients alike.

Background: Patients with Parkinson’s disease (PD) and progressive supranuclear palsy (PSP) suffer from keratoconjunctivitis sicca, also called dry eye (DE) due to rare blinking, reduced tear production and altered composition of tear fluid. This is caused by a physiological dysfunction of the tear drainage. In later stages this can lead to severe visual disturbances with a profound negative impact on quality of life. Therefore early intervention is paramount. If dry eye symptoms are properly recognized during neurological examination patients can be informed accordingly.

Method: Symptoms of dry eye, especially visual disturbances, where identified during admission interviews and examinations of patients with PD and PSP. The questionnaire on non-motor symptoms in Parkinson’s (Nonmotor Symptoms Questionnaire/ (NMSQuest) can be employed to identify dry eye. Treatment was initiated and included artificial tear substitute, ointments or gels. Cases of chronic inflammation of the eyelids were counselled on self-care measures. Frequent check-ups with an ophthalmologist (Sicca Consultation) were always recommended.

Results: Symptoms had a severe negative impact on the quality of life in both patient groups. Artificial tear substitute was already a big relief for many patients and this treatment alone even led to a significant improvement in regards to the spontaneous occlusion of the eyelids (apraxia of the eyelid) in on case of PSP. The negative impact on everyday functioning and quality of life was most notably caused by sensory impairments, visual disturbances and affected edges of the eyelids.

Conclusion: Consistent treatment with artificial tear substitutes, heat, cortisone/cyclosporine or surgery (in severe cases) as well as eye (muscle) training can lead to significant improvements in everyday functioning and overall quality of life.  In addition to heightened attention in neurological diagnostic, close collaboration with ophthalmic colleagues is imperative.

To cite this abstract in AMA style:

I. Csoti, N. Koleva-Alazeh. Dry eye in Parkinson’s disease: symptoms, consequences and treatment options [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/dry-eye-in-parkinsons-disease-symptoms-consequences-and-treatment-options/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/dry-eye-in-parkinsons-disease-symptoms-consequences-and-treatment-options/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley